Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Carine
Carine Alfos, Pessac FR
| Patent application number | Description | Published |
|---|---|---|
| 20090299053 | Product Resulting From the Grafting of Fatty Chains to Ulvans and Use of Said Product as a Surfactant - The invention relates to a product resulting from the grafting, by esterification or transesterification, onto at least a part of the hydroxyl functions of an ulvan-type polysaccharide in the form of an acid or in the form of a mono- or divalent salt, in particular a sodium salt, of fatty chains or of mixtures of fatty chains containing 8 to 28 carbon atoms, said fatty chains being saturated or unsaturated, and linear or branched. | 12-03-2009 |
Carine Alfoss, Pessac FR
| Patent application number | Description | Published |
|---|---|---|
| 20110306526 | LUBRICATING OIL BASED ON POLYOL ESTERS - The present invention relates to oils based on polyol esters, which may be obtained from renewable resources and used as lubricant bases or lubrication additives, notably in four-stroke engine oils, oils for hydraulics or transmissions, as well as industrial lubricants. | 12-15-2011 |
Carine Barataud-Dien, Lambesc FR
| Patent application number | Description | Published |
|---|---|---|
| 20080202080 | High Specific Surface Silicon Carbide Catalytic Filter and Support - The invention relates to a honeycomb structure, made from a porous ceramic material, said structure being characterized in that the porous ceramic material which forms it comprises: | 08-28-2008 |
| 20090139208 | METHOD FOR PREPARING A POROUS STRUCTURE USING SILICA-BASED PORE-FORMING AGENTS - The invention relates to a process for manufacturing a porous silicon carbide structure of the honeycomb type, said process being characterized in that it comprises the following steps: forming of a paste from a mixture of silicon carbide grains, the diameter d | 06-04-2009 |
Carine Bassene, Saint Jean De Bray FR
| Patent application number | Description | Published |
|---|---|---|
| 20090274674 | Heterocyclic Oxime Compounds, Process for Their Preparation and Pharmaceutical Compositions Containing Them - Compounds of formula (I): | 11-05-2009 |
Carine Beriet, Peseux CH
| Patent application number | Description | Published |
|---|---|---|
| 20120036921 | AMPEROMETRIC ELECTROCHEMICAL SENSOR AND METHOD FOR MANUFACTURING SAME - An amperometric electrochemical sensor with a fixed potential used in a probe for measuring the content of an oxidation reduction substance dissolved in a liquid, in particular the chlorine content. The sensor ( | 02-16-2012 |
Carine Beriet Herrera, Peseux CH
| Patent application number | Description | Published |
|---|---|---|
| 20100122905 | AMPEROMETRIC IN-PIPE ELECTROCHEMICAL SENSING PROBE - A sensing probe intended to measure the content of an oxygen reducible substance in a fluid, includes: | 05-20-2010 |
Carine Bernard-Capel, Nanterre FR
| Patent application number | Description | Published |
|---|---|---|
| 20090311689 | Genomic marker for tenderness meat - The invention concerns the use of a genomic marker comprising a nucleotide sequence corresponding to all or part of the nucleotide sequence SEQ ID No. 1, or to all or a part of an allele of the nucleotide sequence SEQ ID No. 1 and associated with the phenotype relating to the tenderness of the meat from bovines, for the implementation of any identification method for the quantification of DNAJA1 expression level with the aim of selecting and/or sorting ruminant animals of the bovine type which produce tender meat and/or for the implementation of an identification method of tender meats at the moment of slaughter by direct sampling from the carcass. | 12-17-2009 |
Carine Bethouart, Feldkirch FR
| Patent application number | Description | Published |
|---|---|---|
| 20100163799 | CORRECTING FLUID WITH DRYING INDICATOR - A correcting fluid with a colored drying indicator that includes as fluorescent dye, sodium 8-hydroxy-1,3,6-pyrenetrisulfonate and a good solvent for the fluorescent dye, in which the solubility of the fluorescent dye at 20° C. is at least equal to 0.1 g/l, and, a poor solvent for the fluorescent dye, in which the solubility of the fluorescent dye is less than or equal to 0.01 g/l at 20° C., the poor solvent being miscible with the good solvent for the fluorescent dye. | 07-01-2010 |
Carine Capiau, Rixensart BE
| Patent application number | Description | Published |
|---|---|---|
| 20080199490 | Immunogenic Composition - The present application discloses an immunogenic composition comprising a Hib saccharide conjugate and at least two further bacterial saccharide conjugates wherein the Hib conjugate is present in a lower saccharide dose than the mean saccharide dose of all the at least two further bacterial saccharide conjugates. | 08-21-2008 |
| 20090041802 | IMMUNOGENIC COMPOSITION - The present application discloses an immunogenic composition comprising | 02-12-2009 |
| 20090136541 | IMMUNOGENIC COMPOSITION - The present application discloses an immunogenic composition comprising at least 2 different | 05-28-2009 |
| 20090252759 | IMMUNOGENIC COMPOSITION - The present application relates to an immunogenic composition comprising at least 2 conjugates of | 10-08-2009 |
| 20100119544 | VACCINE - The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to bacterial polysaccharides conjugated to protein D from | 05-13-2010 |
| 20100291138 | Vaccine - The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to vaccines comprising a pneumococcal polysaccharide antigen, typically a pneumococcal polysaccharide conjugate antigen, formulated with a protein antigen form | 11-18-2010 |
| 20110212124 | Vaccine Composition - The present invention relates to new, advantageous DTP-based combination vaccine formulations, and concomitantly administered combination vaccine kits. Methods of administration of these vaccines and kits are also provided. | 09-01-2011 |
| 20110217329 | Vaccine - The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to vaccines comprising a pneumococcal polysaccharide antigen, typically a pneumococcal polysaccharide conjugate antigen, formulated with a protein antigen form | 09-08-2011 |
Carine Chanut, Ramonville St Agne FR
| Patent application number | Description | Published |
|---|---|---|
| 20090246182 | METHOD FOR CULTURING CELLS DERIVED FROM THE ADIPOSE TISSUE AND USES THEREOF - The invention concerns a method for culturing cells derived from the adipose tissue and in particular the stromal vascular fraction (SVF) to induce formation of cardiomyocytes, the use of the cells obtained by said culture method to reconstitute an ischemized cardiac zone, in particular following an infarction, as well as a pharmaceutical composition containing said cells. The method for obtaining cardiac cells comprises at least the following steps: a) selecting cardiomyogenic cells from the stromal vascular fraction (SVF); b) culturing the cells selected at step a) in a liquid medium optimized for expanding ex vivo the cardiomyogenic cells; c) maintaining and expanding said cells by successive passes in the liquid medium; and d) obtaining cardiac cells. | 10-01-2009 |
Carine Chivas, Saint Cyr L'Ecole FR
| Patent application number | Description | Published |
|---|---|---|
| 20080199697 | Reinforcing Yarns and Composites with an Improved Fire-Resistance - The present invention relates to a composition for reinforcing strands, characterized in that it includes at least one additive capable of acting at the strands/matrix interface so as to improve the fire resistance of the strands/matrix composite, and it also relates to the strands and composites obtained. | 08-21-2008 |
Carine Deleuze-Masquefa, Saint Jean De Vedas FR
| Patent application number | Description | Published |
|---|---|---|
| 20100249142 | IMIDAZOL[1,2-alpha]QUINOXALINES AND DERIVATIVES FOR THE TREATMENT OF CANCERS - Imidazo[1,2-a]quinoxaline compounds for the treatment of cancers as well as pharmaceutical compositions that include these compounds and their uses in therapy. | 09-30-2010 |
Carine Dien-Barataud, Isle FR
| Patent application number | Description | Published |
|---|---|---|
| 20110143928 | CATALYTIC FILTER OR SUBSTRATE CONTAINING SILICON CARBIDE AND ALUMINUM TITANATE - The invention relates to a structure of the honeycomb type, made of a porous ceramic material, said structure being characterized in that the porous ceramic material of which it is composed comprises at least partly 45 to 90% by weight of silicon carbide SiC, preferably in the alpha form, and 10 to 55% by weight of a ceramic oxide phase substantially in the form of aluminum titanate Al | 06-16-2011 |
| 20110176972 | CELLULAR STRUCTURE CONTAINING ALUMINIUM TITANATE - The invention relates to a structure of the honeycomb type, comprising a porous ceramic material based on aluminum titanate, the thermal expansion coefficient of which between 20 and 1000° C. is less than 2.5×10 | 07-21-2011 |
| 20110185690 | SIC/GLASS-CERAMIC COMPOSITE FILTER - The invention relates to a filter of which the filtering portion is made from an inorganic material comprising grains of SiC bonded by a vitroceramic phase, to form a porous structure of which the apparent porosity is between 20 and 70%, said vitroceramic bonding phase comprising at least the following components, in molar percentage of the total oxides present in said phase: | 08-04-2011 |
| 20110190120 | PARTICLE BLEND FOR SYNTHESIZING A POROUS STRUCTURE OF THE ALUMINIUM TITANATE TYPE - The invention relates to a particle blend comprising mainly or consisting of an oxide phase of the pseudo-brookite type comprising at least titanium and aluminum, said blend being obtained from at least two particle size fractions, namely a coarse particle size fraction, the median diameter d | 08-04-2011 |
Carine Gachon, Arpajon FR
Carine Giovannangeli, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20100047192 | Novel tyrosinase-specific anti-gene oligonucleotides as depigmenting agents - The present invention relates to an anti-gene oligonucleotide which hybridizes specifically with the gene encoding human tyrosinase by Hoogsteen pairing between the complementary bases, said oligonucleotide forming a triple helix structure with the human tyrosinase gene. The invention also relates to the use of said oligonucleotide as a skin-depigmenting or skin-bleaching agent in a cosmetic composition or in a dermatological composition. | 02-25-2010 |
Carine Goraj, Rixensart BE
| Patent application number | Description | Published |
|---|---|---|
| 20100291137 | METHOD FOR REFOLDING NEISSERIAL NSPA PROTEIN - The present invention provides an isolated refolded NspA protein, and a method of preparing it. | 11-18-2010 |
| 20110033500 | VACCINE COMPOSITIONS COMPRISING L2 AND/OR L3 IMMUNOTYPE LIPOOLIGOSACCHARIDES FROM LGTB-NEISSERIA MENINGITIDIS - The present invention relates to the field of neisserial vaccine compositions, their manufacture, and the use of such compositions in medicine. More particularly it relates to processes of making novel engineered meningococcal strains which are more suitable for the production of neisserial, in particular meningococcal, outer-membrane vesicle (or bleb) vaccines. Advantageous processes and vaccine products are also described based on the use of novel LOS subunit or meningococcal outer-membrane vesicle (or bleb) vaccines which have been rendered safer and/or more effective for use in human subjects. In particular combinations of gene downregulations are described such as PorA and OpA, PorA and OpC, OpA and OpC, and PorA and OpA and OpC. Alternatively, or in addition, lgtB | 02-10-2011 |
| 20120027800 | NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS - The present invention relates to immunogenic compositions and vaccines for the treatment and prevention of Neisserial disease. Immunogenic compositions of the invention contain combinations of antigens selected from at least two different classes of antigens including adhesins, autotransporter proteins, toxins, iron acquisitions proteins and membrane-associated protein (preferably integral outer membrane protein)s. Such combinations of antigens are able to target the immune response against different aspects of the neisserial life cycle, resulting in a more effective immune response. | 02-02-2012 |
| 20120064119 | NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS - The present invention relates to immunogenic compositions and vaccines for the treatment and prevention of Neisserial disease. Immunogenic compositions of the invention contain combinations of antigens selected from at least two different classes of antigens including adhesins, autotransporter proteins, toxins, iron acquisitions proteins and membrane-associated protein (preferably integral outer membrane protein)s. Such combinations of antigens are able to target the immune response against different aspects of the neisserial life cycle, resulting in a more effective immune response. | 03-15-2012 |
| 20120064120 | NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS - The present invention relates to immunogenic compositions and vaccines for the treatment and prevention of Neisserial disease. Immunogenic compositions of the invention contain combinations of antigens selected from at least two different classes of antigens including adhesins, autotransporter proteins, toxins, iron acquisitions proteins and membrane-associated protein (preferably integral outer membrane protein)s. Such combinations of antigens are able to target the immune response against different aspects of the neisserial life cycle, resulting in a more effective immune response. | 03-15-2012 |
Carine Maggetto, Rixensart BE
| Patent application number | Description | Published |
|---|---|---|
| 20120077268 | ANIMAL-FREE CELL CULTURE METHOD - The present invention relates to a process for culturing animal cells, e.g., human, diploid anchorage-dependent cells, in the absence of exogenous components of primary animal origin. In particular, the invention provides cell culture media substantially free of exogenous components of primary and secondary animal origin which comprises at least one, more preferably several, exogenous animal-free growth factors. The present invention also relates to a process for cultivating animal cells using a protease of non-animal origin for passaging cells. | 03-29-2012 |
Carine Metz-Favre, Strasbourg FR
| Patent application number | Description | Published |
|---|---|---|
| 20080261215 | Method for Evaluating the Allergen Sensitivity of an Individual - The present invention discloses a method for evaluating the allergen sensitivity of an individual and/or the clinical efficacy of an allergen immunotherapy comprising the steps: providing at least two samples selected from the group consisting of blood or fractions thereof, connective tissue, nasal, bronchial, skin or gut biopsy material from an individual subjected or intended to be subjected to an immunotherapy with at least one pure allergen or derivative thereof, wherein the samples contain cells capable of releasing mediators in response to said allergen, contacting said sample with said allergen or derivative thereof, and determining the amounts of mediators released from said sample and evaluating the allergen sensitivity of the individual prior to therapy and/or the clinical efficacy of the immunotherapy by comparing said amounts. | 10-23-2008 |
Carine Mirman, Sainte Croix De Quintillargues FR
| Patent application number | Description | Published |
|---|---|---|
| 20100308178 | VARIABLE RATIO CRANK FOR A MANUAL FLIGHT CONTROL LINKAGE OF A ROTARY WING AIRCRAFT - The present invention relates to a bellcrank ( | 12-09-2010 |
Carine Moncourt, Pins Justaret FR
| Patent application number | Description | Published |
|---|---|---|
| 20080319671 | Method For Predicting Collisions With Obstacles on the Ground and Generating Warnings, Notably on Board an Aircraft - The invention notably relates to a method of detecting obstacles on the ground receiving an obstacle clearance sensor and a zone for extracting map data. The method comprises the following steps: | 12-25-2008 |
Carine Nizard, Ivry Sur Seine FR
| Patent application number | Description | Published |
|---|---|---|
| 20100055217 | COSMETIC COMPOSITION COMPRISING A COMBINATION OF LIPOCHROMAN-6 AND AN EXTRACT OF LONGOZA, AND ITS USE - The invention relates to a cosmetic composition formulated for topical application to the skin, comprising as active agent a combination of lipochroman-6 and an extract of Longoza ( | 03-04-2010 |
| 20100063139 | USE IN A COSMETIC COMPOSITION OF LIPOCHROMAN-6 TO ENHANCE THE RADIANCE OF THE COMPLEXION OF THE SKIN, ESPECIALLY THE SKIN OF THE FACE - The invention relates to the use, in a cosmetic composition intended for topical application to the skin, of lipochroman-6 as an active intended to enhance and/or restore the radiance of the complexion of the skin, especially the skin of the face. | 03-11-2010 |
| 20100092506 | USE OF PHAEODACTYLUM ALGAE EXTRACT FOR DEPIGMENTING THE SKIN - The invention relates to the use in a cosmetic composition of an extract of the alga | 04-15-2010 |
| 20100266650 | METHOD OF COSMETIC CARE STIMULATING MITOCHONDRIAL ACONITASE - The invention relates to the use of a plant extract as a cosmetic agent. | 10-21-2010 |
| 20100310616 | METHOD OF COSMETIC CARE STIMULATING MITOCHONDRIAL ACONITASE - The invention relates to a cosmetic care method for preventing or retarding the appearance of the signs of ageing of the skin or for attenuating the effects thereof. | 12-09-2010 |
| 20110229431 | METHODS USEFUL IN STUDYING OR MODULATING SKIN OR HAIR PIGMENTATION, PLANT EXTRACTS FOR USE IN COMPOSITIONS AND COSMETIC CARE METHOD - The invention relates to methods useful in studying or modulating skin or hair pigmentation and to the use of plant extracts in compositions as well as to methods comprising the topical use of such compositions to reduce or to enhance skin or hair pigmentation. | 09-22-2011 |
| 20110262551 | COSMETIC COMPOSITION - A cosmetic composition includes, as a cosmetic active agent, a honey from clover ( | 10-27-2011 |
| 20110268812 | Cosmetic or dermatological composition comprising the combination of honey and a peptide - A cosmetic composition has a combination of honey or royal jelly, and a peptide, including at least the amino acid sequence Gly-X | 11-03-2011 |
Carine Nizard, Ivry S/seine FR
| Patent application number | Description | Published |
|---|---|---|
| 20120003164 | COSMETIC OR DERMATOLOGICAL COMPOSITION CONTAINING AN ACTIVE AGENT WHICH STIMULATES SYNTHESIS OF THE PROTEIN HSP 32 IN THE SKIN - A dermatological or cosmetological composition for an external topical administration, included together with pharmaceutically and/or cosmetologically acceptable excipients: at least one UVA-stabilizing and/or UVB-stabilizing screening agent, at least one compound capable of activating the endogenous synthesis of Heat Shock Protein (HSP) 32 or a functional peptide fragment of such a protein, and forskolin or any extract containing it. | 01-05-2012 |
Carine Nyalendo, Montreal CA
| Patent application number | Description | Published |
|---|---|---|
| 20110305750 | MEMBRANE TYPE-1 MATRIX METALLOPROTEIN INHIBITORS AND USES THEREOF - Based on the discovery that a soluble polypeptide including a nonphosphorylatable form of the cytoplasmic domain is capable of inhibiting in a dominant negative manner, the present invention provides compositions including MT1-MMP inhibitors such as peptide inhibitors, and methods for treating diseases associated with MT1-MMP activity. Such diseases include cancer, arthritis, and heart disease, and vascular disease. | 12-15-2011 |
Carine Petit-Clair, Montesson FR
| Patent application number | Description | Published |
|---|---|---|
| 20110201857 | Process For The Preparation Of Multimetallic Catalysts That Can Be Used In Reactions For Transformation Of Hydrocarbons - The invention relates to a process for the preparation of a catalyst comprising: | 08-18-2011 |
Carine Petit-Clair, Jardin FR
| Patent application number | Description | Published |
|---|---|---|
| 20100236986 | CATALYST COMPRISING PALLADIUM AND ITS APPLICATION IN SELECTIVE HYDROGENATION - The invention concerns a catalyst comprising a porous support, palladium, at least one metal selected from the group constituted by alkalis and alkaline-earths, in which: | 09-23-2010 |
Carine Roquelaure, Aix En Provence FR
| Patent application number | Description | Published |
|---|---|---|
| 20100114410 | METHOD OF ENSURING THE INTEGRITY OF FLIGHT DATA AND A SYSTEM FOR IMPLEMENTING SAID METHOD - A method of transferring and processing flight data of an aircraft including recording the aircraft flight data in an onboard avionics system in a digital format so as to obtain digital data, the flight data including safety impact flight data and flight data having no recognized effect on safety. The method further includes recording at least the safety impact flight data in the onboard avionics system in an additional format dissimilar to the digital format so as to obtain additional flight data, storing the digital data and the additional flight data separately, transferring the digital data and the additional flight data to a monitoring computer on the ground, displaying the digital data on a screen in the form of display digital data, and transferring the digital data and the additional flight data to a complementary interpretation unit so as to generate one of display data and print data relating to the additional flight data. | 05-06-2010 |
Carine Simon-Desplats, La Seyne-Sur-Mer FR
| Patent application number | Description | Published |
|---|---|---|
| 20080199928 | Producing Hydrogen By Heterologous Expression Of A Type II Nad (P)H Deshydrogenase In Chlamydomonas - The invention concerns the use of a type II NAD(P)H dehydrogenase (NDH-II), or of a polynucleotide encoding said NDH-II, to increase the capacity of a green algae to produce hydrogen. Said polynucleotide is in particular useful for transforming said green algae, so as to improve its hydrogen production. | 08-21-2008 |
Carine Viornery, Carantec FR
| Patent application number | Description | Published |
|---|---|---|
| 20100234900 | ENDOSSEOUS IMPLANT - Endosseous implant to be applied to a human or animal bone, wherein the surface of the implant is made from titanium or a titanium alloy, said implant having a smooth or rough surface texture, which is characterized in that said surface has been treated with at least one selected organic phosphonate compound or a pharmaceutically acceptable salt or ester or an amide thereof; process for producing said implants. | 09-16-2010 |